vimarsana.com

Latest Breaking News On - Replicel life sciences inc - Page 1 : vimarsana.com

RepliCel Life Sciences Inc Reports Earnings Results for the Full Year Ended December 31, 2023

RepliCel Life Sciences Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CAD 0.311734 million compared to CAD 0.743228.

Replicel life sciences incReplicel life sciences

RepliCel Life Sciences : Announces Secured Loan Agreement

RepliCel Announces Secured Loan Agreement VANCOUVER, BC, CANADA -April 17, 2024 - RepliCel Life Sciences Inc. , a company developing next-generation technologies in.

United statesUnited kingdomHong kongBritish columbiaAndrew schutteMainpointe pharmaceuticalsBc ltdReplicel life sciences incReplicel life sciencesCanadian securities exchangeChina health companyReplicel announces secured loanCel life sciencesChief executive officerMultilateral instrumentMinority security holders

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -November 30, 2023 at 01:09 pm EST

REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended September 30, 2023 and 2022 .

United statesBritish columbiaHong kongLee bucklerDavid hallReplicel life sciences incCompany stock option planCompany or replicelInternational financial reporting standardsShiseido companyCompany optionsVenture exchangeParty transactionsBus partnershipTrichoscience innovations incInternational accounting standards board

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -October 24, 2023 at 11:14 am EDT

REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended June 30, 2023 and 2022 .

British columbiaHong kongUnited statesLee bucklerDavid hallParty transactionsBus partnershipVenture exchangeTrichoscience innovations incInternational financial reporting standardsCompany optionsShiseido companyChina health industry coReplicel life sciences incMainpointe pharmaceuticalsInternational accounting standards board

Innovate BC Awards $1 365M to B C R&D Projects Solving

Innovations in natural resources and applied sciences with the potential to change the world.

British columbiaProvince of british columbiaUnited kingdomBehraad bahreyniMohsen akbariAlexandre broloLaurel schaferBrenda baileyAdam clareTomica divicLife sciencesRapidia tech incSimon fraser universityVoxcell bioinnovation incUniversity of victoriaO advanced materials inc

vimarsana © 2020. All Rights Reserved.